- Home
- ATOM vs AVTX Comparison
ATOM vs AVTX Comparison
Compare ATOM & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOM
- AVTX
- Stock Information
- Founded
- ATOM 2001
- AVTX 2011
- Country
- ATOM United States
- AVTX United States
- Employees
- ATOM N/A
- AVTX N/A
- Industry
- ATOM Semiconductors
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ATOM Technology
- AVTX Health Care
- Exchange
- ATOM Nasdaq
- AVTX Nasdaq
- Market Cap
- ATOM 155.4M
- AVTX 57.4M
- IPO Year
- ATOM 2016
- AVTX 2015
- Fundamental
- Price
- ATOM $5.05
- AVTX $5.09
- Analyst Decision
- ATOM Strong Buy
- AVTX Strong Buy
- Analyst Count
- ATOM 1
- AVTX 7
- Target Price
- ATOM $7.00
- AVTX $31.00
- AVG Volume (30 Days)
- ATOM 561.6K
- AVTX 122.3K
- Earning Date
- ATOM 07-29-2025
- AVTX 08-11-2025
- Dividend Yield
- ATOM N/A
- AVTX N/A
- EPS Growth
- ATOM N/A
- AVTX N/A
- EPS
- ATOM N/A
- AVTX N/A
- Revenue
- ATOM $121,000.00
- AVTX $441,000.00
- Revenue This Year
- ATOM $202.22
- AVTX N/A
- Revenue Next Year
- ATOM $1,225.00
- AVTX N/A
- P/E Ratio
- ATOM N/A
- AVTX $0.74
- Revenue Growth
- ATOM N/A
- AVTX N/A
- 52 Week Low
- ATOM $2.31
- AVTX $3.39
- 52 Week High
- ATOM $17.55
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- ATOM 41.60
- AVTX 57.49
- Support Level
- ATOM $4.85
- AVTX $4.76
- Resistance Level
- ATOM $5.17
- AVTX $5.05
- Average True Range (ATR)
- ATOM 0.29
- AVTX 0.30
- MACD
- ATOM -0.02
- AVTX 0.03
- Stochastic Oscillator
- ATOM 36.67
- AVTX 84.75
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).